Compare the 9 manufacturers holding an active US Drug Master File for Ganirelix API, with DMF numbers and filing years from the FDA's quarterly DMF list.
Directory listing last reviewed October 2026.
9 manufacturers hold an active Type II Drug Master File for GanirelixAPI, taken from the FDA's quarterly DMF list. A DMF lets a drug applicant reference the maker's manufacturing data. It is not an FDA approval. Check each manufacturer against the FDA import alert lists before ordering.
| Manufacturer | Location | US DMF | Filed |
|---|---|---|---|
| Aspen API (Aspen Oss) | Netherlands | 13971 | 1999 |
| Sun Pharmaceutical IndustriesFDA import alert | India (Mumbai) | 25866 | 2012 |
| BCN Peptides | Spain (Barcelona) | 29585 | 2015 |
| Hybio Pharmaceutical | China | 30800 | 2016 |
| Chengdu Shengnuo BiopharmFDA import alert | China | 33546 | 2019 |
| Auro Peptides | India (Hyderabad) | 36108 | 2021 |
| Apicore (RK Pharma) | USA (East Windsor, NJ) | 36902 | 2022 |
| Harbin Jixianglong BiotechFDA import alert | China (Harbin) | 39994 | 2024 |
| HLB PEP (formerly AnyGen) | South Korea | 40573 | 2024 |
Request API quotes from several manufacturers at once.